Publicaciones en las que colabora con MARÍA ISABEL MARTÍNEZ GRAS (10)

2013

  1. Cognition and the five-factor model of the Positive and Negative Syndrome Scale in schizophrenia

    Schizophrenia Research, Vol. 143, Núm. 1, pp. 77-83

  2. Negative symptoms and executive function in schizophrenia: Does their relationship change with illness duration?

    Psychopathology, Vol. 46, Núm. 4, pp. 241-248

2012

  1. Altered immune function in unaffected first-degree biological relatives of schizophrenia patients

    Psychiatry Research, Vol. 200, Núm. 2-3, pp. 1022-1025

  2. Psychopathologic differences between cannabis-induced psychoses and recent-onset primary psychoses with abuse of cannabis

    Comprehensive Psychiatry, Vol. 53, Núm. 8, pp. 1063-1070

2011

  1. The anti-inflammatory prostaglandin 15d-PGJ2 and its nuclear receptor PPARgamma are decreased in schizophrenia

    Schizophrenia Research, Vol. 128, Núm. 1-3, pp. 15-22

2010

  1. Executive function in schizophrenia: Influence of substance use disorder history

    Schizophrenia Research, Vol. 118, Núm. 1-3, pp. 34-40

2009

  1. Differential dorsolateral prefrontal cortex activation during a verbal n-back task according to sensory modality

    Behavioural Brain Research, Vol. 205, Núm. 1, pp. 299-302

2007

  1. Endocannabinoid system and CNR1 gene polymorphisms in schizophrenia and addictive disorders

    Actas Espanolas de Psiquiatria, Vol. 35, Núm. 2, pp. 122-129

2006

  1. (AAT)n repeat in the cannabinoid receptor gene, CNR1: Association with schizophrenia in a Spanish population

    European Archives of Psychiatry and Clinical Neuroscience, Vol. 256, Núm. 7, pp. 437-441

  2. The effects of topiramate adjunctive treatment added to antidepressants in patients with resistant obsessive-compulsive disorder [7]

    Journal of Clinical Psychopharmacology